Recovery of vitamin D levels by cholecalciferol supplementation on obese rats

Dea Anenta Veonika; Budiyanti Wiboworini; Muthmainah Muthmainah

doi:10.21927/ijnd.2024.1(1).40-48

Recovery of vitamin D levels by cholecalciferol supplementation on obese rats

Dea Anenta Veonika, Budiyanti Wiboworini, Muthmainah Muthmainah

Abstract

ABSTRAK

Latar Belakang: Obesitas disebabkan oleh penumpukan lemak dalam tubuh karena faktor biologis, psikososial, dan perilaku. Prevalensi obesitas mencapai 42,24% di Amerika Serikat, sementara overweight dan obesitas mencapai 59% di Eropa. Obesitas dapat menyebabkan defisiensi vitamin D melalui berbagai mekanisme.

Tujuan: Untuk mengatahui pengaruh pemberian suplementasi cholecalciferol terhadap kadar 25(OH)D pada tikus obesitas.

Metode: Dalam penelitian ini, kami melakukan penelitian true experiment with. pre-post test control group design. Penelitian ini menganalisis 3 kelompok tikus galur Sprague Dawley jantan yang diinduksi dengan diet tinggi lemak tinggi fruktosa (HFHF) menjadi tikus obesitas. Masing-masing kelompok mendapatkan cholecalciferol sebanyak 2,500 IU/200gr/hari pada kelompok P1, 5,000IU/200gr/hari pada kelompok P2, dan 10,000 IU/200gr/hari pada kelompok P3 selama 8 minggu. Tikus kemudian dianalisis kadar serum 25(OH)D sebelum dan sesudah perlakuan.

Hasil: Suplementasi cholecalciferol secara signifikan meningkatkan kadar vitamin D pada setiap kelompok intervensi yang diberikan cholecalciferol. Rerata kadar 25(OH)D kelompok P1,P2, dan P3 sebelum perlakuan berturut-turut adalah 29,43±0,83 ng/mL, 28,61±1,57 ng/mL, dan 28,86±1,46 ng/mL. Rerata kadar 25(OH)D setelah suplementasi cholecalciferol untuk kelompok P1,P2, dan P3 berturut-turut adalah 74,27±0,77 ng/mL, 100,30±1,48 ng/mL, dan 126,73±2,30 ng/mL. Ada perbedaan yang signifikan antara nilai 25(OH)D sebelum dan sesudah perlakuan pada ketiga kelompok intervensi dengan nilai (p<0,05).

Kesimpulan: Pemberian cholecalciferol mampu meningkatkan kadar 25(OH)D pada tikus jantan yang diinduksi obesitas.

KATA KUNCI: cholecalciferol; obesitas; vitamin D

ABSTRACT

Background: Obesity is caused by the accumulation of fat in the body due to biological, psychosocial and behavioral factors. The prevalence of obesity reaches 42.24% in the United States, while overweight and obesity reaches 59% in Europe. Obesity can cause vitamin D deficiency through various mechanisms.

Objectives: To determine the effect of cholecalciferol supplementation on 25(OH)D levels in obese mice.

Methods: In this research, we conducted a true experiment research with pre-post test control group design. This study analyzed 3 groups of male Sprague Dawley rats that were induced by a high-fat, high-fructose (HFHF) diet to become obese rats. Each group received 2,500 IU/200gr/day of cholecalciferol in group P1, 5,000IU/200gr/day in group P2, and 10,000 IU/200gr/day in group P3 for 8 weeks. The mice were then analyzed for serum 25(OH)D levels before and after treatment.

Results: Cholecalciferol supplementation significantly increased vitamin D levels in each intervention group given cholecalciferol. The mean 25(OH)D levels in groups P1, P2, and P3 before treatment were 29.43 ± 0.83 ng/mL, 28.61 ± 1.57 ng/mL, and 28.86 ± 1.46, respectively. ng/mL. The mean 25(OH)D levels after cholecalciferol supplementation for groups P1, P2, and P3 were 74.27±0.77 ng/mL, 100.30±1.48 ng/mL, and 126.73±2 respectively. .30 ng/mL. There was a significant difference between the 25(OH)D values before and after treatment in the three intervention groups with values (p<0.05).

Conclusion: Administration of cholecalciferol can increase 25(OH)D levels in male mice that are induced by obesity.

KEYWORDS: cholecalciferol, vitamin D, obesity

Keywords

cholecalciferol; obesitas; vitamin D; cholecalciferol, vitamin D, obesity

Full Text:

PDF

References

Purnell JQ. Definitions, Classification, and Epidemiology of Obesity. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editor. South Dartmouth (MA); 2000.

Ahmad S, Imam K syed. Obesity: A Practical Guide. Ahmad S, Imam K syed, editor. Elsevier; 2016.

Oktavia SN. Hubungan Kadar Vitamin D Dalam Darah Dengan Kejadian Obesitas Pada Siswa Sma Pembangunan Padang. J Akad Baiturrahim Jambi. 2019;8(1):1.

Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Vol. 133, Metabolism: clinical and experimental. United States; 2022. hal. 155217.

Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics [Internet]. Vol. 12, Frontiers in Endocrinology . 2021. Tersedia pada: https://www.frontiersin.org/articles/10.3389/fendo.2021.706978

Kementerian Kesehatan Republik Indonesia. Laporan Nasional Riset Kesehatan Dasar. Kementeri Kesehat RI. 2018;1–582.

Apovian CM. Obesity: definition, comorbidities, causes, and burden. Am J Manag Care. Juni 2016;22(7 Suppl):s176-85.

Avtanski D, Garcia A, Liao E. Vitamin D and Obesity. In: Liao E, editor. Extraskeletal Effects of Vitamin D Contemporary Endocrinology [Internet]. Humana Press; 2018. Tersedia pada: https://doi.org/10.1007/978-3-319-73742-3_9

Lapik IA, Galchenko A V, Gapparova KM. Micronutrient status in obese patients: A narrative review. Obes Med [Internet]. 2020;18:100224. Tersedia pada: https://www.sciencedirect.com/science/article/pii/S2451847620300440

Vranić L, Mikolašević I, Milić S. Vitamin D Deficiency: Consequence or Cause of Obesity? Medicina (Kaunas). Agustus 2019;55(9).

Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. Desember 2017;24(6):389–94.

Louisa M, Paramita. Berbagai Manfaat Vitamin D. Dep Farmakol dan Ter Fak Kedokt Univ Indones Jakarta, Indones. 2017;44(10):736–40.

Bouillon R, Manousaki D, Rosen C, Trajanoska K, Rivadeneira F, Richards JB. The health effects of vitamin D supplementation: evidence from human studies. Nat Rev Endocrinol. Februari 2022;18(2):96–110.

Khosravi ZS, Kafeshani M, Tavasoli P, Zadeh AH, Entezari MH. Effect of Vitamin D Supplementation on Weight Loss, Glycemic Indices, and Lipid Profile in Obese and Overweight Women: A Clinical Trial Study. Int J Prev Med. 2018;9:63.

Holick MF. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord. Juni 2017;18(2):153–65.

Hanafy AS, Elkatawy HA. Beneficial Effects of Vitamin D on Insulin Sensitivity, Blood Pressure, Abdominal Subcutaneous Fat Thickness, and Weight Loss in Refractory Obesity. Clin Diabetes. Juli 2018;36(3):217–25.

Nair R, Maseeh A. Vitamin D: The “sunshine” vitamin. J Pharmacol Pharmacother. April 2012;3(2):118–26.

Karampela I, Sakelliou A, Vallianou N, Christodoulatos GS, Magkos F, Dalamaga M. Vitamin D and Obesity: Current Evidence and Controversies. Curr Obes Rep. 1 Juni 2021;10.

Pereira-Santos M, Costa PRF, Assis AMO, Santos CAST, Santos DB. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev an Off J Int Assoc Study Obes. April 2015;16(4):341–9.

Lotfi-Dizaji L, Mahboob S, Aliashrafi S, Vaghef-Mehrabany E, Ebrahimi-Mameghani M, Morovati A. Effect of vitamin D supplementation along with weight loss diet on meta-inflammation and fat mass in obese subjects with vitamin D deficiency: A double-blind placebo-controlled randomized clinical trial. Clin Endocrinol (Oxf). Januari 2019;90(1):94–101.

Sekel NM, Gallo S, Fields J, Jagim AR, Wagner T, Jones MT. The Effects of Cholecalciferol Supplementation on Vitamin D Status Among a Diverse Population of Collegiate Basketball Athletes: A Quasi-Experimental Trial. Nutrients. Januari 2020;12(2).

Žmitek K, Hribar M, Hristov H, Pravst I. Efficiency of Vitamin D Supplementation in Healthy Adults is Associated with Body Mass Index and Baseline Serum 25-Hydroxyvitamin D Level. Nutrients. April 2020;12(5).

Quraishi SA, De Pascale G, Needleman JS, Nakazawa H, Kaneki M, Bajwa EK, et al. Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial. Crit Care Med. September 2015;43(9):1928–37.

Sosa Henríquez M, Gómez de Tejada Romero MJ. Cholecalciferol or Calcifediol in the Management of Vitamin D Deficiency. Nutrients. Mei 2020;12(6).

Ramasamy I. Vitamin D Metabolism and Guidelines for Vitamin D Supplementation. Clin Biochem Rev. Desember 2020;41(3):103–26.

Karonova T, Grineva E, Belyaeva O, Bystrova A, Jude EB, Andreeva A, et al. Relationship Between Vitamin D Status and Vitamin D Receptor Gene Polymorphisms With Markers of Metabolic Syndrome Among Adults. Front Endocrinol (Lausanne). 2018;9:448.

Carrelli A, Bucovsky M, Horst R, Cremers S, Zhang C, Bessler M, et al. Vitamin D Storage in Adipose Tissue of Obese and Normal Weight Women. J bone Miner Res Off J Am Soc Bone Miner Res. Februari 2017;32(2):237–42.

Surdu AM, Pînzariu O, Ciobanu D-M, Negru A-G, Căinap S-S, Lazea C, et al. Vitamin D and Its Role in the Lipid Metabolism and the Development of Atherosclerosis. Vol. 9, Biomedicines. 2021.

Yarparvar A, Elmadfa I, Djazayery A, Abdollahi Z, Salehi F. The Association of Vitamin D Status with Lipid Profile and Inflammation Biomarkers in Healthy Adolescents. Nutrients. Februari 2020;12(2).

DOI: http://dx.doi.org/10.21927/ijnd.2024.1(1).40-48